Overview

Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)

Status:
Not yet recruiting

Trial end date:
2024-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to learn about the safety and effects of PLG0206 for treating acute periprosthetic joint infections (PJI) in conjunction with the DAIR (debridement, antibiotics and implant retention) surgical procedure for patients with acute periprosthetic joint infections (PJI) after total knee arthroplasty (TKA) .

Phase:

Phase 1

Details

Lead Sponsor:

Peptilogics

Collaborators:

Department of Health and Human Services
Wellcome Trust